Terumo Corp.

Terumo is engaged in the manufacture and sale of medical products and equipment. Co.'s principal businesses are cardiac and vascular, general hospital, and blood management. Co.'s principal products are I.V. catheter, nelaton catheter, surgical tape, wound care dressing, syringe hypodermic needle, safety syringe and IV administration set; angiographic catheter, PTCA dilatation catheter, coronary stent, microcatheter and artificial vascular grafts; automated blood collection system, automated blood component processing device, blood bag system with leukocyte reduction filter, sterile tubing welder, pathogen reduction technology system, therapeutic apheresis system, and cell expansion system.
  • Ticker4543
  • ISINJP3546800008
  • SectorHealth Care Equipment & Services
  • CountryJapan

An unfavourable environment weighs on TERUMO CORPORATION, which sees a downgrade to Slightly Negative

The independent financial analyst theScreener just requalified the general evaluation of TERUMO CORPORATION (JP), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as moderately risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Slightly Negative. As of the analysis date March 3, 2020, the closing price was JPY 3,505.00 and its target price was estimated at JPY 3,317.06.

Feasibility Study Results in December to be a Catalyst for this Junior

Feasibility Study Results in December to be a Catalyst for this Junior

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Health Care Hitting On All Cylinders Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the MSCI ACWI following the late-October breakout... see chart below. • Market Ignoring Negative Headlines. Global equity markets continue to generally shrug off seemingly bearish headlines surrounding trade, Trump impeachment hearings, and ongoing protests in Hong Kong. This tells us that the good outweighs the bad in the eyes of the market. While we view the fact that none of these issues have yet to derail global m...

Dave Nicoski ...
  • Ross LaDuke

Vermilion Int'l Compass: Global Equity Strategy

Health Care Hitting On All Cylinders Global equities remain in a short-term consolidation phase, however we continue to believe the longer-term trend is up and to the right for the MSCI ACWI following the late-October breakout... see chart below. • Market Ignoring Negative Headlines. Global equity markets continue to generally shrug off seemingly bearish headlines surrounding trade, Trump impeachment hearings, and ongoing protests in Hong Kong. This tells us that the good outweighs the bad in the eyes of the market. While we view the fact that none of these issues have yet to derail global m...